Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
ACCORD BP (Action to ControlCardiovascular Risk in Diabetes —Blood–Pressure-lowering arm)
ACCORD BP (Action to Control Cardiovascular Risk inDiabetes — Blood–Pressure-lowering arm)W C Cushman (Veterans Affairs Me...
ACCORD BP: Results• No significant difference in the primary end point as well as in the prespecified  secondary end point...
ACCORD BP: Commentary*"In my opinion its now probably reasonable to forget all about the 130-mm-Hg goal[in diabetics], eve...
Become a member of http://www.theheart.org    Become a fan on Facebook: http://www.facebook.com/theheartorg          Follo...
Upcoming SlideShare
Loading in …5
×

ACCORD BP trial - Summary & Results

2,245 views

Published on

http://www.theheart.org/web_slides/1146197.do

A randomized study,on action to control cardiovascular risk in diabetes and blood-pressure-lowering arm (ACCORD BP) in a nonblinded fashion, to intensive BP-lowering

Published in: Health & Medicine
  • Be the first to comment

ACCORD BP trial - Summary & Results

  1. 1. ACCORD BP (Action to ControlCardiovascular Risk in Diabetes —Blood–Pressure-lowering arm)
  2. 2. ACCORD BP (Action to Control Cardiovascular Risk inDiabetes — Blood–Pressure-lowering arm)W C Cushman (Veterans Affairs Medical Center, Memphis, TN)American College of Cardiology 2010 Scientific Sessions• Background: Designed to provide clinical-trial evidence to support recommendations to lower SBP <130 mm Hg in type 2 diabetes—as advised in JNC 7 guidelines• Population and treatment: 4733 patients with type 2 diabetes Randomized, in a nonblinded fashion, to intensive BP-lowering with target SBP<120 mm Hg, or standard BP lowering with target SBP<140 mm Hg• Primary outcome: A composite of fatal and nonfatal major CV eventsSBP=systolic blood pressure
  3. 3. ACCORD BP: Results• No significant difference in the primary end point as well as in the prespecified secondary end points between the groupsPrimary and secondary outcomesa Outcome Intensive therapy Intensive therapy Standard therapy Standard therapy Hazard p (n=2363), events, n (n=2363), %/y (n=2371), events, n (n=2371), %/y ratio Primary outcome 208 1.87 237 2.09 0.88 0.20 Secondary outcomes Nonfatal MI 126 1.13 146 1.28 0.87 0.25 Stroke – Any 36 0.32 62 0.53 0.59 0.01 – Nonfatal 34 0.30 55 0.47 0.63 0.03 Death – Any cause 150 1.28 144 1.19 1.07 0.55 – CV cause 60 0.52 58 0.49 1.06 0.74a. At a median of 4.7 years
  4. 4. ACCORD BP: Commentary*"In my opinion its now probably reasonable to forget all about the 130-mm-Hg goal[in diabetics], even though we didnt test that. Everything in terms of clinical-trialevidence would suggest that 140 mm Hg is an appropriate goal . . .There is no reason to say that we shouldnt treat [high] blood pressure indiabetics—we should, its extremely important to get them down to the levels atwhich we have shown benefit, consistent with our standard group." - Dr William C Cushman*All comments from ACCORD BP: Intensive BP lowering futile in diabetics(http://www.theheart.org/article/1054543.do)
  5. 5. Become a member of http://www.theheart.org Become a fan on Facebook: http://www.facebook.com/theheartorg Follow us on Twitter: http://www.twitter.com/theheartorgtheheart.org is the leading online source of independent cardiology news.We are the top provider of news and opinions for over 100 000 physicians.

×